Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 20.0

(-9.91%)

Inventory Summary of Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.'s latest annual inventory in 2023 was 53.77 Million TWD , up 58.23% from previous year.
Welgene Biotech Co.,Ltd.'s latest quarterly inventory in 2024 Q2 was 62.98 Million TWD , up 33.55% from previous quarter.
Welgene Biotech Co.,Ltd. reported annual inventory of 33.98 Million TWD in 2022, up 25.9% from previous year.
Welgene Biotech Co.,Ltd. reported annual inventory of 26.99 Million TWD in 2021, up 46.92% from previous year.
Welgene Biotech Co.,Ltd. reported quarterly inventory of 62.98 Million TWD for 2024 Q2, up 33.55% from previous quarter.
Welgene Biotech Co.,Ltd. reported quarterly inventory of 53.77 Million TWD for 2023 FY, up 58.23% from previous quarter.

Annual Inventory Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Inventory of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year	Inventory	Inventory Growth
2023	53.77 Million TWD	58.23%
2022	33.98 Million TWD	25.9%
2021	26.99 Million TWD	46.92%
2020	18.37 Million TWD	-30.67%
2019	26.5 Million TWD	-28.81%
2018	37.22 Million TWD	-19.27%
2017	46.11 Million TWD	30.08%
2016	35.44 Million TWD	25.91%
2015	28.15 Million TWD	-2.76%
2014	28.95 Million TWD	0.0%

Year	Inventory	Inventory Growth
2024 Q1	45.84 Million TWD	-14.75%
2024 Q2	62.98 Million TWD	33.55%
2023 FY	53.77 Million TWD	58.23%
2023 Q3	44.65 Million TWD	-20.68%
2023 Q4	53.77 Million TWD	20.41%
2023 Q1	33.92 Million TWD	-0.18%
2023 Q2	56.3 Million TWD	65.98%
2022 Q3	25.44 Million TWD	-29.28%
2022 Q2	35.98 Million TWD	-37.27%
2022 Q1	57.36 Million TWD	112.51%
2022 FY	33.98 Million TWD	25.9%
2022 Q4	33.98 Million TWD	33.55%
2021 Q1	39.37 Million TWD	114.34%
2021 Q3	47.07 Million TWD	-1.89%
2021 Q4	26.99 Million TWD	-42.66%
2021 FY	26.99 Million TWD	46.92%
2021 Q2	47.98 Million TWD	21.85%
2020 Q4	18.37 Million TWD	-37.77%
2020 FY	18.37 Million TWD	-30.67%
2020 Q3	29.52 Million TWD	-33.28%
2020 Q2	44.25 Million TWD	0.0%
2020 Q1	- TWD	-100.0%
2019 Q2	48.99 Million TWD	0.0%
2019 Q1	48.99 Million TWD	31.62%
2019 FY	26.5 Million TWD	-28.81%
2019 Q4	26.5 Million TWD	0.0%
2018 Q4	37.22 Million TWD	0.0%
2018 FY	37.22 Million TWD	-19.27%
2018 Q1	37.42 Million TWD	-18.84%
2018 Q2	37.42 Million TWD	0.0%
2018 Q3	37.22 Million TWD	-0.52%
2017 Q2	34.09 Million TWD	0.0%
2017 Q1	34.09 Million TWD	-3.81%
2017 Q4	46.11 Million TWD	0.0%
2017 Q3	46.11 Million TWD	35.24%
2017 FY	46.11 Million TWD	30.08%
2016 FY	35.44 Million TWD	25.91%
2016 Q4	35.44 Million TWD	0.0%
2016 Q3	35.44 Million TWD	0.0%
2015 FY	28.15 Million TWD	-2.76%
2014 FY	28.95 Million TWD	0.0%

Peer Inventory Comparison of Welgene Biotech Co.,Ltd.

Name	Inventory	Inventory Difference
BIONET Corp.	55.53 Million TWD	3.183%
DIVA Laboratories, Ltd.	196.2 Million TWD	72.595%
Genetics Generation Advancement Corp.	34.79 Million TWD	-54.52%
Puriblood Medical Co., Ltd.	24.24 Million TWD	-121.759%
TFBS Bioscience Inc.	8.84 Million TWD	-508.052%